ALIOS BIOPHARMA

alios-biopharma-logo

Alios is discovering and developing novel therapeutic agents based on three platform technologies including: small molecule activators of innate immunity antiviral pathways (RNase L activation), phosphate protected nucleotide prodrug chemistry, and glycoprotein-engineering of interferons (Glycoferonรƒยข). This complementary group of platform technologies has the potential to generate a number of distinct therapeutic products to treat a variety of serious viral infections such as chronic hepatitis B and C, HIV infection, and respiratory viruses (e.g. pandemic influenza) and emerging viral diseases (e.g. SARS).

#SimilarOrganizations #People #Financial #Website #More

ALIOS BIOPHARMA

Social Links:

Industry:
Biopharma Biotechnology Therapeutics

Founded:
2006-01-01

Address:
South San Francisco, California, United States

Country:
United States

Website Url:
http://www.aliosbiopharma.com

Total Employee:
51+

Status:
Closed

Contact:
650-635-5500

Email Addresses:
[email protected]

Total Funding:
74.4 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Google Tag Manager Apple Mobile Web Clips Icon Google Analytics HSTS Google Maps Content Delivery Network Font Awesome


Similar Organizations

sagimet-biosciences-logo

Sagimet Biosciences

Sagimet Biosciences is a biotechnology company that focuses on developing novel therapeutics to treat important diseases.

bridgebio-pharma-logo

BridgeBio Pharma

BridgeBio Pharma focuses on genetic disease therapies and develops those assets with the right approach in supporting R&D.

cti-biopharma-logo

CTI BioPharma

CTI BioPharma is a biopharmaceutical company developing oncology products for the treatment of cancer.

enclear-therapies-logo

EnClear Therapies

EnClear Therapies is a biotechnology company developing device-based therapies for the treatment of neurodegenerative disease

kodiak-sciences-logo

Kodiak Sciences

Kodiak is designing and developing novel therapies for the treatment of retinal disease.

milestone-pharmaceuticals-logo

Milestone Pharmaceuticals

Milestone Pharmaceuticals is a drug development company developing small molecule therapeutics for the treatment of cardiovascular diseases.

ngm-biopharmaceuticals-logo

NGM Biopharmaceuticals

NGM Biopharmaceuticals is a drug discovery company developing biotherapeutics for the gastrointestinal endocrine system.

numab-logo

Numab

Numab is a biotechnology company that offers antibody-based therapeutics for the treatment of severe diseases.

triana-biomedicines-logo

Triana Biomedicines

Triana Biomedicines is a developer of a molecular glue discovery platform to regulate disease.

zura-bio-logo

Zura Bio

Zura Bio is a clinical-stage biotechnology company that develops medicines for immune system disorders.


Current Advisors List

not_available_image

Ernest Borden Scientific Advisors @ Alios BioPharma
Advisor

not_available_image

Martin Moore Scientific Advisors @ Alios BioPharma
Advisor

not_available_image

Octavio Ramilo Scientific Advisors @ Alios BioPharma
Advisor

not_available_image

Rachel Fearns Scientific Advisors @ Alios BioPharma
Advisor

not_available_image

Daniel Herschlag Scientific Advisors @ Alios BioPharma
Advisor

not_available_image

Michael G Ison Scientific Advisors @ Alios BioPharma
Advisor

not_available_image

John DeVincenzo Scientific Advisors @ Alios BioPharma
Advisor

kent-gossett_image

Kent Gossett Board of Directors @ Alios BioPharma
Board_member

Current Employees Featured

not_available_image

Leonid Beigelman
Leonid Beigelman Founder, Chief Scientific Officer @ Alios BioPharma
Founder, Chief Scientific Officer
2010-01-01

cheng-kao_image

Cheng Kao
Cheng Kao Senior Research Fellow @ Alios BioPharma
Senior Research Fellow
2019-05-01

Founder


not_available_image

John Donovan

lawrence-blatt_image

Lawrence Blatt

not_available_image

Leonid Beigelman

Investors List

sr-one_image

SR One

SR One investment in Series B - Alios BioPharma

novartis-venture-fund_image

Novartis Venture Fund

Novartis Venture Fund investment in Series B - Alios BioPharma

roche-venture-fund_image

Roche Venture Fund

Roche Venture Fund investment in Series B - Alios BioPharma

novo-ventures_image

Novo Ventures

Novo Ventures investment in Series B - Alios BioPharma

novo-a-s_image

Novo Holdings

Novo Holdings investment in Venture Round - Alios BioPharma

roche-venture-fund_image

Roche Venture Fund

Roche Venture Fund investment in Series A - Alios BioPharma

novartis-venture-fund_image

Novartis Venture Fund

Novartis Venture Fund investment in Series A - Alios BioPharma

novo-ventures_image

Novo Ventures

Novo Ventures investment in Series A - Alios BioPharma

novo-ventures_image

Novo Ventures

Novo Ventures investment in Series A - Alios BioPharma

roche-venture-fund_image

Roche Venture Fund

Roche Venture Fund investment in Series A - Alios BioPharma

Official Site Inspections

http://www.aliosbiopharma.com

  • Host name: a6033b2998aeb1ff7.awsglobalaccelerator.com
  • IP address: 99.83.186.106
  • Location: Seattle United States
  • Latitude: 47.54
  • Longitude: -122.3032
  • Metro Code: 819
  • Timezone: America/Los_Angeles
  • Postal: 98108

Loading ...

More informations about "Alios BioPharma"

Alios BioPharma - Crunchbase Company Profile

Organization. Alios BioPharma . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. Alios โ€ฆSee details»

Organization | Alios BioPharma

Organization Overview. First Clinical Trial. 2011 NCT01554085. First Marketed Drug. None โ€ฆSee details»

Alios BioPharma - Funding, Financials, Valuation & Investors

Alios BioPharma is a biotechnology company developing novel medicines for the treatment of โ€ฆSee details»

Alios BioPharma Company Overview, Contact Details

Alios BioPharma is a clinical stage biopharmaceutical company in South San Francisco, โ€ฆSee details»

Alios BioPharma, Inc. - Drug pipelines, Patents, Clinical trials

Nov 1, 2024 Explore Alios BioPharma, Inc. with its drug pipeline, therapeutic area, technology โ€ฆSee details»

Alios BioPharma - PitchBook

Alios BioPharma General Information Description. Developer of novel antiviral therapies for treatment of acute and chronic infections. The company's discovery platform includes a proprietary chemical library of nucleoside analogs and โ€ฆSee details»

Alios BioPharma - VentureRadar

" Alios BioPharma is a privately-held biotechnology company located in South San Francisco, โ€ฆSee details»

Alios BioPharma - Products, Competitors, Financials, Employees ...

Alios BioPharma is a privately-held biotechnology company located in South San Francisco, โ€ฆSee details»

Alios BioPharma | EquityNet

Alios is discovering and developing novel therapeutic agents based on three platform โ€ฆSee details»

Alios BioPharma - Contacts, Employees, Board Members

Alios BioPharma is a biotechnology company developing novel medicines for the treatment of โ€ฆSee details»

Johnson & Johnson Announces Completion Of Alios Biopharma โ€ฆ

Nov 7, 2014 The acquisition includes Alios BioPharmaโ€™s portfolio of potential therapeutics for โ€ฆSee details»

Alios BioPharma - Scientist.com

Alios BioPharma 260 East Grand Avenue South San Francisco, CA, 94080 United States ... If โ€ฆSee details»

Johnson & Johnson completes acquisition of AliosBioPharma for โ€ฆ

Based in California, US, AliosBioPharma develops therapies for the treatment of viral diseases. โ€ฆSee details»

Johnson & Johnson buying Alios for $1.75B | AP News

Sep 30, 2014 NEW BRUNSWICK, N.J. (AP) โ€” Johnson & Johnson is buying the โ€ฆSee details»

Alios BioPharma Employee Directory, Headcount & Staff | LeadIQ

Alios BioPharma is a clinical stage biopharmaceutical company in South San Francisco, โ€ฆSee details»

Alios BioPharma: From Startup To Big Pharma - Life Science Leader

Jun 1, 2016 If you had told Lawrence Blatt a decade ago that he and his team from then โ€ฆSee details»

Low-profile Alios gets a roster of Big Pharma funds to back anti โ€ฆ

Apr 8, 2014 Even after out-licensing a pair of hepatitis C therapeutic candidates to Vertex, โ€ฆSee details»

Emerging Drug Developer: Alios BioPharma - Fierce Biotech

Feb 17, 2009 Alios sets sights on new, improved interferon molecule A fledgling South San โ€ฆSee details»

Alios BioPharma - VentureRadar

Alios BioPharma is a privately-held biotechnology company located in South San Francisco, โ€ฆSee details»

J&J dumps Alios RSV drug, wiping remaining $900M off value

Mar 22, 2019 Johnson & Johnson has abandoned development of anti-RSV drug AL-8176, โ€ฆSee details»

linkstock.net © 2022. All rights reserved